DO US MANAGED CARE ORGANIZATIONS RESTRICT COVERAGE MORE THAN THE FOOD AND DRUG ADMINISTRATION LABEL?

被引：0
|
作者：
Da Conceicao, R. [1 ]
Narvekar, P. [1 ]
Okorozo, P. [2 ]
机构：
[1] Avalere Hlth, New York, NY USA
[2] Avalere Hlth, Buffalo, NY USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR116
引用
收藏
页码：S214 / S215
页数：2
相关论文
共 50 条
  • [21] Update on Novel Drugs for Primary Care Practice: Drugs Approved by the US Food and Drug Administration in 2015
    Smetana, Gerald W.
    ANNALS OF INTERNAL MEDICINE, 2016, 164 (09) : W48 - W54
  • [22] Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death
    Lalani, Christina
    Kunwar, Elysha M.
    Kinard, Madris
    Dhruva, Sanket S.
    Redberg, Rita F.
    JAMA INTERNAL MEDICINE, 2021, 181 (09) : 1217 - 1223
  • [23] Drug benefit plans under managed care: To what extent do older subscribers selecting less drug coverage put themselves at increased financial risk?
    Andrade, SE
    Gurwitz, JH
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (01) : 178 - 181
  • [24] The association between proton pump inhibitors and myocardial infarction: What do food and drug administration data tell us?
    Tan, Jiun Ming
    Parsons, Richard
    Sim, Tin Fei
    Lee, Ya Ping
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2019, 8 (03) : 123 - 128
  • [25] US Food and Drug Administration and Off-Label Use of Metal Expandable Biliary Stents within the Peripheral Vasculature-Update
    Marrone, April K.
    Gottschalk, Laura
    Chen, Allen L.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 31 (04) : 622 - 628
  • [26] Unjustified Increase in Cost of Care Resulting From US Food and Drug Administration Approval of Makena (17α-Hydroxyprogesterone Caproate)
    Cohen, Arnold W.
    Copel, Joshua A.
    Macones, George A.
    Menard, M. Kathryn
    Riley, Laura
    Saade, George R.
    OBSTETRICS AND GYNECOLOGY, 2011, 117 (06): : 1408 - 1410
  • [27] Advancing a managed care pharmacy research agenda: Generating real-world evidence to support US Food and Drug Administration Accelerated Approvals and improving benefit design to address health inequities
    Brixner, Diana
    Couto, Joe
    Worley, Karen
    Small, Amber
    Panchal, Rupesh
    Dharbhamalla, Vyishali
    Eichenbrenner, Paula
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (08): : 911 - 917
  • [28] Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death COMMENT & RESPONSE
    Chang, Dong W.
    Parrish, Jennifer
    Yee, Hal F., Jr.
    JAMA INTERNAL MEDICINE, 2021,
  • [29] Silicone Breast Implants and Magnetic Resonance Imaging Screening for Rupture: Do US Food and Drug Administration Recommendations Reflect an Evidence-Based Practice Approach to Patient Care?
    Gray, Lawrence
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2008, 122 (05) : 1591 - 1592
  • [30] SCIENCE-BASED ETHNIC BRIDGING IN CLINICAL DRUG DEVELOPMENT: REVIEW OF RECENT (2014-2018) US FOOD AND DRUG ADMINISTRATION PRECEDENCE AND LABEL CLAIMS.
    van Hoogdalem, E. -J.
    Jones, J.
    Achira, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S35 - S35
12345